Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 104075-48-1
2. Atipamezole Hcl
3. Atipamezole (hydrochloride)
4. 4-(2-ethyl-2,3-dihydro-1h-inden-2-yl)-1h-imidazole Hydrochloride
5. Mpv-1248 Hydrochloride
6. 1h-imidazole, 4-(2-ethyl-2,3-dihydro-1h-inden-2-yl)-, Monohydrochloride
7. 5-(2-ethyl-2,3-dihydro-1h-inden-2-yl)-1h-imidazole Hydrochloride
8. Mfcd06407819
9. 2w4279571x
10. 104075-48-1 (hcl)
11. 5-(2-ethyl-2,3-dihydro-1h-indene-2-yl)-1h-imidazole Hydrochloride
12. 4-(2-ethyl-2-indanyl)imidazole Hydrochloride
13. Ncgc00182707-02
14. Unii-2w4279571x
15. Atipamezolehydrochloride
16. Mpv1248 Hydrochloride
17. Mpv 1248 Hydrochloride
18. Dsstox_cid_28509
19. Dsstox_rid_82781
20. Dsstox_gsid_48583
21. Schembl203964
22. Chembl2361649
23. Dtxsid2048583
24. 5-(2-ethyl-1,3-dihydroinden-2-yl)-1h-imidazole;hydrochloride
25. Act08567
26. Amy10903
27. Bcp04113
28. Tox21_112912
29. S4649
30. Atipamezole Hydrochloride [mi]
31. Akos015918212
32. Akos025401424
33. Ac-1613
34. Bcp9000339
35. Ccg-266950
36. Cs-3389
37. Atipamezole Hydrochloride [mart.]
38. As-66133
39. Hy-12380
40. Sy057281
41. B7226
42. Cas-104075-48-1
43. Ft-0656606
44. Atipamezole Hydrochloride [green Book]
45. F20658
46. 075a481
47. 5-(2-ethyl-indan-2-yl)-1h-imidazole Hydrochloride
48. J-504668
49. Q27255684
50. Atipamezole Hydrochloride 100 Microg/ml In Acetonitrile
51. 4-(2-ethyl-1,3-dihydroinden-2-yl)-1h-imidazole;hydrochloride
Molecular Weight | 248.75 g/mol |
---|---|
Molecular Formula | C14H17ClN2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 2 |
Exact Mass | 248.1080262 g/mol |
Monoisotopic Mass | 248.1080262 g/mol |
Topological Polar Surface Area | 28.7 Ų |
Heavy Atom Count | 17 |
Formal Charge | 0 |
Complexity | 237 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Market Place
ABOUT THIS PAGE
A Atipamezole Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Atipamezole Hydrochloride, including repackagers and relabelers. The FDA regulates Atipamezole Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Atipamezole Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Atipamezole Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Atipamezole Hydrochloride supplier is an individual or a company that provides Atipamezole Hydrochloride active pharmaceutical ingredient (API) or Atipamezole Hydrochloride finished formulations upon request. The Atipamezole Hydrochloride suppliers may include Atipamezole Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Atipamezole Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Atipamezole Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Atipamezole Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Atipamezole Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Atipamezole Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Atipamezole Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Atipamezole Hydrochloride suppliers with NDC on PharmaCompass.
Atipamezole Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Atipamezole Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Atipamezole Hydrochloride GMP manufacturer or Atipamezole Hydrochloride GMP API supplier for your needs.
A Atipamezole Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Atipamezole Hydrochloride's compliance with Atipamezole Hydrochloride specifications and serves as a tool for batch-level quality control.
Atipamezole Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Atipamezole Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Atipamezole Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Atipamezole Hydrochloride EP), Atipamezole Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Atipamezole Hydrochloride USP).
LOOKING FOR A SUPPLIER?